The present invention relates to methods and pharmaceutical compositions for the treatment of neurodegeneration with brain iron accumulation (NBIA). In particular, the present invention relates to a method of treating neurodegeneration with brain iron accumulation comprising administering to the subject a therapeutically effective amount of a drug increasing TfR1 palmitoylation.